Black-Eyed Peas and Lentils Top the List for Blocking Cancer-Spreading Enzymes
Certain beans outperform others at inhibiting MMP-9, the enzyme that drives cancer metastasis — responsible for 90% of cancer deaths.
Summary
Researchers tested eight legumes for their ability to block matrix metalloproteinases (MMPs) — enzymes that allow cancer to spread through tissue and into the bloodstream. Since metastasis accounts for roughly 90% of cancer-related deaths, inhibiting MMPs is a high-value target. Pharmaceutical MMP inhibitors failed in humans due to severe side effects, but proteins found in legumes show natural inhibitory activity. In lab testing, black-eyed peas, lentils, common beans like kidney and black beans, and fava beans cut MMP enzyme activity by more than half. Split peas showed minimal effect. This research, summarized by Dr. Michael Greger, builds on broader evidence that plant-based dietary compounds can disrupt multiple steps of the cancer invasion process, offering a potentially low-risk, accessible dietary strategy for cancer prevention and metastasis control.
Detailed Summary
Cancer metastasis — the spreading of tumors from their original site to other tissues and organs — is responsible for approximately 90% of cancer-related deaths. A class of enzymes called matrix metalloproteinases (MMPs) plays a central role in this process by allowing cancer cells to tunnel through surrounding tissue and enter the lymphatic or blood systems. Blocking these enzymes is therefore a compelling target for cancer prevention and treatment.
Pharmaceutical companies developed MMP-inhibitor drugs that worked well in animal models but caused severe side effects in humans, making them clinically unviable. Researchers have since turned to dietary phytochemicals as a potentially safer alternative. Evidence summarized by Dr. Michael Greger of NutritionFacts.org suggests that plant bioactive compounds can inhibit nearly every step of the invasion-metastasis cascade, at least under laboratory conditions.
A key study tested eight legumes — lupin beans, chickpeas, split peas, black-eyed peas, lentils, common beans (kidney, black, pinto), fava beans, and soybeans — for their ability to reduce MMP activity. Black-eyed peas, lentils, common beans, and fava beans demonstrated the strongest inhibition, cutting enzyme activity by more than half. Split peas showed little measurable effect. The active agents appear to be specific proteins unique to legumes rather than general plant compounds.
This fits within a broader dietary framework supported by substantial epidemiological and mechanistic evidence: diets rich in diverse whole plant foods — including berries, leafy greens, legumes, nuts, seeds, garlic, onions, mushrooms, and green tea — are consistently associated with reduced cancer risk and slower disease progression.
Important caveats apply. Much of the MMP-inhibition data comes from in vitro (petri dish) studies, which do not always translate to human physiology. Clinical trials confirming these specific effects in cancer patients are lacking. Nonetheless, incorporating a variety of legumes into a regular diet carries negligible risk and substantial potential benefit.
Key Findings
- Black-eyed peas, lentils, fava beans, and common beans cut MMP-9 cancer-spreading enzyme activity by over 50% in lab tests.
- Split peas showed minimal MMP-inhibiting activity compared to other legumes tested.
- Matrix metalloproteinases drive roughly 90% of cancer deaths by enabling tumor metastasis through tissue invasion.
- Pharmaceutical MMP inhibitors failed clinically due to severe side effects; dietary legume proteins offer a safer alternative pathway.
- A broad whole-food plant-based diet including berries, greens, garlic, mushrooms, and green tea targets multiple cancer hallmarks simultaneously.
Methodology
This is a research summary and science communication piece authored by Dr. Michael Greger, MD FACLM, drawing on published peer-reviewed studies. NutritionFacts.org is a credible, nonprofit, evidence-based platform. Primary evidence cited includes in vitro laboratory studies comparing legume proteins' effects on MMP enzyme activity, supplemented by broader epidemiological and mechanistic literature on plant compounds and cancer.
Study Limitations
The primary MMP-inhibition data comes from in vitro studies, which frequently do not replicate in human clinical trials. The article does not cite specific study names or journals, making independent verification of primary sources difficult. No human randomized controlled trial data is presented to confirm that bean consumption meaningfully reduces MMP activity or metastasis rates in vivo.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.